✦ LIBER ✦

Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection

✍ Scribed by Stephanos J. Hadziyannis

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 432 KB
Volume: 8
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840080348

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled clinical trial of acyclovir i

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

✍ Dr. Graeme J. M. Alexander; Elizabeth A. Fagan; John E. Hegarty; Adrian L. W. F. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi

A randomised controlled trial of recombi

A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection

✍ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNγ) 0.1 mg/m^2^ intramuscularly thrice weekly for

Autoantibody prevalence in chronic hepat

Autoantibody prevalence in chronic hepatitis B virus infection: Effect in interferon alfa

✍ G V Gregorio; H Jones; K Choudhuri; A Vegnente; F Bortolotti; G Mieli-Vergani; D 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

albeit with different prevalences, and a third report suggests The most effective treatment of chronic hepatitis B that IFN-a may be a trigger for autoimmune hepatitis. 13 To virus (HBV) infection is interferon alfa (IFN-a), a potenaddress the question as to whether any clinical or serological tiall

Acyclovir in chronic hepatitis B virus i

Acyclovir in chronic hepatitis B virus infection

✍ Geoffrey M. Dusheiko 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 2 views

In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati

AFP in chronic hepatitis B virus infecti

AFP in chronic hepatitis B virus infection

✍ Yun-Fan Liaw; Anna Lok 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a

Lymphoblastoid interferon alfa with or w

Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: A multicenter controlled trial

✍ G V Gregorio; P Jara; L Hierro; C Diaz; A de la Vega; A Vegnente; R Iorio; F Bor 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

## Steroid priming does not potentiate the effect of IFN-a. The comparative efficacy of prednisolone followed by (HEPATOLOGY 1996;23:700-707.) interferon alfa (IFN-a) versus IFN-a alone in enhancing the rate of antibody to hepatitis B e antigen (anti-HBe) seroconversion has not been evaluated in a